Literature DB >> 29088324

Network Structure and Function in Parkinson's Disease.

Ji Hyun Ko1, Phoebe G Spetsieris1, David Eidelberg1,2.   

Abstract

Little is known of the structural and functional properties of abnormal brain networks associated with neurological disorders. We used a social network approach to characterize the properties of the Parkinson's disease (PD) metabolic topography in 4 independent patient samples and in an experimental non-human primate model. The PD network exhibited distinct features. Dense, mutually facilitating functional connections linked the putamen, globus pallidus, and thalamus to form a metabolically active core. The periphery was formed by weaker connections linking less active cortical regions. Notably, the network contained a separate module defined by interconnected, metabolically active nodes in the cerebellum, pons, frontal cortex, and limbic regions. Exaggeration of the small-world property was a consistent feature of disease networks in parkinsonian humans and in the non-human primate model; this abnormality was only partly corrected by dopaminergic treatment. The findings point to disease-related alterations in network structure and function as the basis for faulty information processing in this disorder.

Entities:  

Mesh:

Year:  2018        PMID: 29088324      PMCID: PMC6215468          DOI: 10.1093/cercor/bhx267

Source DB:  PubMed          Journal:  Cereb Cortex        ISSN: 1047-3211            Impact factor:   5.357


  61 in total

1.  Abnormal metabolic brain networks in a nonhuman primate model of parkinsonism.

Authors:  Yilong Ma; Shichun Peng; Phoebe G Spetsieris; Vesna Sossi; David Eidelberg; Doris J Doudet
Journal:  J Cereb Blood Flow Metab       Date:  2011-11-30       Impact factor: 6.200

2.  Network modulation in the treatment of Parkinson's disease.

Authors:  Kotaro Asanuma; Chengke Tang; Yilong Ma; Vijay Dhawan; Paul Mattis; Christine Edwards; Michael G Kaplitt; Andrew Feigin; David Eidelberg
Journal:  Brain       Date:  2006-07-14       Impact factor: 13.501

3.  Long-term follow-up of a randomized AAV2-GAD gene therapy trial for Parkinson's disease.

Authors:  Martin Niethammer; Chris C Tang; Peter A LeWitt; Ali R Rezai; Maureen A Leehey; Steven G Ojemann; Alice W Flaherty; Emad N Eskandar; Sandra K Kostyk; Atom Sarkar; Mustafa S Siddiqui; Stephen B Tatter; Jason M Schwalb; Kathleen L Poston; Jaimie M Henderson; Roger M Kurlan; Irene H Richard; Christine V Sapan; David Eidelberg; Matthew J During; Michael G Kaplitt; Andrew Feigin
Journal:  JCI Insight       Date:  2017-04-06

4.  Functional similarities and distance properties.

Authors:  Michael Muskulus; Sanne Houweling; Sjoerd Verduyn-Lunel; Andreas Daffertshofer
Journal:  J Neurosci Methods       Date:  2009-07-07       Impact factor: 2.390

5.  Consistent abnormalities in metabolic network activity in idiopathic rapid eye movement sleep behaviour disorder.

Authors:  Ping Wu; Huan Yu; Shichun Peng; Yves Dauvilliers; Jian Wang; Jingjie Ge; Huiwei Zhang; David Eidelberg; Yilong Ma; Chuantao Zuo
Journal:  Brain       Date:  2014-10-22       Impact factor: 13.501

6.  Metabolic network expression in parkinsonism: Clinical and dopaminergic correlations.

Authors:  Ji Hyun Ko; Chong Sik Lee; David Eidelberg
Journal:  J Cereb Blood Flow Metab       Date:  2016-07-21       Impact factor: 6.200

7.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

8.  Identification of disease-related spatial covariance patterns using neuroimaging data.

Authors:  Phoebe Spetsieris; Yilong Ma; Shichun Peng; Ji Hyun Ko; Vijay Dhawan; Chris C Tang; David Eidelberg
Journal:  J Vis Exp       Date:  2013-06-26       Impact factor: 1.355

9.  Parkinson's disease-related network topographies characterized with resting state functional MRI.

Authors:  An Vo; Wataru Sako; Koji Fujita; Shichun Peng; Paul J Mattis; Frank M Skidmore; Yilong Ma; Aziz M Uluğ; David Eidelberg
Journal:  Hum Brain Mapp       Date:  2016-05-21       Impact factor: 5.038

10.  Modulation of metabolic brain networks after subthalamic gene therapy for Parkinson's disease.

Authors:  Andrew Feigin; Michael G Kaplitt; Chengke Tang; Tanya Lin; Paul Mattis; Vijay Dhawan; Matthew J During; David Eidelberg
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-27       Impact factor: 11.205

View more
  13 in total

1.  LRRK2 and GBA Variants Exert Distinct Influences on Parkinson's Disease-Specific Metabolic Networks.

Authors:  Katharina A Schindlbeck; An Vo; Nha Nguyen; Chris C Tang; Martin Niethammer; Vijay Dhawan; Vicky Brandt; Rachel Saunders-Pullman; Susan B Bressman; David Eidelberg
Journal:  Cereb Cortex       Date:  2020-05-14       Impact factor: 5.357

2.  Novel Analysis Identifying Functional Connectivity Patterns Associated with Posttraumatic Stress Disorder.

Authors:  Natalie Wright; Ronak Patel; Sarah J Chaulk; Gillian Alcolado; David Podnar; Natalie Mota; Candice M Monson; Todd A Girard; Ji Hyun Ko
Journal:  Chronic Stress (Thousand Oaks)       Date:  2022-04-18

3.  Brain metabolic alterations herald falls in patients with Parkinson's disease.

Authors:  Ioannis U Isaias; Joachim Brumberg; Nicoló G Pozzi; Chiara Palmisano; Andrea Canessa; Giorgio Marotta; Jens Volkmann; Gianni Pezzoli
Journal:  Ann Clin Transl Neurol       Date:  2020-03-11       Impact factor: 4.511

4.  Brain Functional and Structural Signatures in Parkinson's Disease.

Authors:  Chunhua Liu; Jiehui Jiang; Hucheng Zhou; Huiwei Zhang; Min Wang; Juanjuan Jiang; Ping Wu; Jingjie Ge; Jian Wang; Yilong Ma; Chuantao Zuo
Journal:  Front Aging Neurosci       Date:  2020-05-26       Impact factor: 5.750

5.  Individual brain metabolic connectome indicator based on Kullback-Leibler Divergence Similarity Estimation predicts progression from mild cognitive impairment to Alzheimer's dementia.

Authors:  Min Wang; Jiehui Jiang; Zhuangzhi Yan; Ian Alberts; Jingjie Ge; Huiwei Zhang; Chuantao Zuo; Jintai Yu; Axel Rominger; Kuangyu Shi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-04-22       Impact factor: 9.236

Review 6.  Circuit imaging biomarkers in preclinical and prodromal Parkinson's disease.

Authors:  Sanne K Meles; Wolfgang H Oertel; Klaus L Leenders
Journal:  Mol Med       Date:  2021-09-16       Impact factor: 6.354

7.  Dopamine depletion and subcortical dysfunction disrupt cortical synchronization and metastability affecting cognitive function in Parkinson's disease.

Authors:  Linbo Wang; Cheng Zhou; Wei Cheng; Edmund T Rolls; Peiyu Huang; Ningning Ma; Yuchen Liu; Yajuan Zhang; Xiaojun Guan; Tao Guo; Jingjing Wu; Ting Gao; Min Xuan; Quanquan Gu; Xiaojun Xu; Baorong Zhang; Weikang Gong; Jingnan Du; Wei Zhang; Jianfeng Feng; Minming Zhang
Journal:  Hum Brain Mapp       Date:  2021-12-14       Impact factor: 5.038

Review 8.  Modulating brain networks associated with cognitive deficits in Parkinson's disease.

Authors:  Iman Beheshti; Ji Hyun Ko
Journal:  Mol Med       Date:  2021-03-10       Impact factor: 6.354

9.  Brain Atrophy and Reorganization of Structural Network in Parkinson's Disease With Hemiparkinsonism.

Authors:  Xiaojun Xu; Xiaojun Guan; Tao Guo; Qiaoling Zeng; Rong Ye; Jiaqiu Wang; Jianguo Zhong; Min Xuan; Quanquan Gu; Peiyu Huang; Jiali Pu; Baorong Zhang; Minming Zhang
Journal:  Front Hum Neurosci       Date:  2018-03-27       Impact factor: 3.169

10.  Elevated caudate connectivity in cognitively normal Parkinson's disease patients.

Authors:  Natalie Wright; Abrar Alhindi; Colleen Millikin; Mandana Modirrousta; Sean Udow; Andrew Borys; Julius Anang; Douglas E Hobson; Ji Hyun Ko
Journal:  Sci Rep       Date:  2020-10-21       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.